Andrea Low, MD, PhD is an assistant professor of epidemiology at the Mailman School of Public Health. She studied Marine Biology at the University of British Columbia and then received her MD from McGill University, and completed her Infectious Diseases medical specialization at New York University. As a Wellcome Trust Research Fellow, she received a PhD in epidemiology at the London School of Hygiene and Tropical Medicine, where she focused on HIV transmission and reproductive health in female sex workers in Burkina Faso. Dr Low is currently the Lead Epidemiologist on the multi-country Population-Based HIV Impact Assessment (PHIA), and the Project Director for the Lesotho Violence Against Children Survey (VACS). Her research interests include HIV acquisition in vulnerable populations and the heterogeneity of infection and risk, including among adolescents and young adults (AGYW), as well as common co-infections affecting people living with HIV. She is also currently working with PHIA data in analyses on the impact of climate change and drought on HIV and risk behaviors in southern Africa.
PhD, 2014, London School of Hygiene and Tropical Medicine
MSc, 2008, London School of Hygiene and Tropical Medicine
MD, 2000, McGill University
BSc, 1994, University of British Columbia
Areas of Expertise
Intervention Studies, Longitudinal Studies, Adolescent Health, Immigrant Health, Women's Health, Climate and Health, Molecular Epidemiology, Hunger/Food Insecurity, Poverty, HIV/AIDS, Sexually Transmitted Infections, Antiretrovirals, Epidemics, Hepatitis, Infectious Disease, Tuberculosis, Lesbian / Gay / Bisexual / Transgender Health, Reproductive Health
Select Global Activities
Population-Based HIV Impact Assessment (PHIA), Cameroon, Ethiopia, Lesotho, Namibia, Rwanda, Swaziland, Tanzania, Uganda, Zambia, Zimbabwe
Low AJ, Mburu G, Welton NJ, May MT, Davies CF, French C, Turner KM, Looker KJ, Christensen H, McLean S, Rhodes T, Platt L, Hickman M, Guise A, Vickerman P. Impact of Opioid Substitution Therapy on Antiretroviral Therapy Outcomes: A Systematic Review and Meta-Analysis. Clinical infectious diseases. 2016; 63(8):1094-1104.
Mukandavire C, Low A, Mburu G, Trickey A, May MT, Davies CF, French CE, Looker KJ, Rhodes T, Platt L, Guise A, Hickman M, Vickerman P. Impact of opioid substitution therapy on the HIV prevention benefit of antiretroviral therapy for people who inject drugs. AIDS. 2017; 31(8):1181-1190.
Low A, Nagot N, Konate I, Meda N, Segondy M, Van de Perre P, Mayaud P, Vickerman P. Potential impact of existing interventions and of antiretroviral use in female sex workers on transmission of HIV in Burkina Faso: a modeling study. Journal of acquired immune deficiency syndromes (1999). 2015; 68 Suppl 2:S180-8.
Guise A, Seguin M, Mburu G, McLean S, Grenfell P, Islam Z, Filippovych S, Assan H, Low A, Vickerman P, Rhodes T. Integrated opioid substitution therapy and HIV care: a qualitative systematic review and synthesis of client and provider experiences.AIDS care. 2017; 29(9):1119-1128.
Low A, Gavriilidis G, Larke N, B-Lajoie MR, Drouin O, Stover J, Muhe L, Easterbrook P. Incidence of Opportunistic Infections and the Impact of Antiretroviral Therapy Among HIV-Infected Adults in Low- and Middle-Income Countries: A Systematic Review and Meta-analysis. Clinical infectious diseases: 2016; 62(12):1595-1603.
B-Lajoie MR, Drouin O, Bartlett G, Nguyen Q, Low A, Gavriilidis G, Easterbrook P, Muhe L.Incidence and Prevalence of Opportunistic and Other Infections and the Impact of Antiretroviral Therapy Among HIV-infected Children in Low- and Middle-income Countries: A Systematic Review and Meta-analysis.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2016; 62(12):1586-1594.
Cianci F, Sweeney S, Konate I, Nagot N, Low A, Mayaud P, Vickerman P. The cost of providing combined prevention and treatment services, including ART, to female sex workers in Burkina Faso. PloS one. 2014; 9(6):e100107
Low A, Prada N, Topper M, Vaida F, Castor D, Mohri H, Hazuda D, Muesing M, Markowitz M .Natural polymorphisms of human immunodeficiency virus type 1 integrase and inherent susceptibilities to a panel of integrase inhibitors.Antimicrobial agents and chemotherapy. 2009; 53(10):4275-82.
Low AJ, Konate I, Nagot N, Weiss HA, Kania D, Vickerman P, Segondy M, Mabey D, Pillay D, Meda N, van de Perre P, Mayaud P. Cervicovaginal HIV-1 shedding in women taking antiretroviral therapy in Burkina Faso: a longitudinal study. Journal of acquired immune deficiency syndromes (1999). 2014; 65(2):237-45.
Herpes Simplex Virus Type-2 Cervicovaginal Shedding Among Women Living With HIV-1 and Receiving Antiretroviral Therapy in Burkina Faso: An 8-Year Longitudinal Study. Low AJ, Nagot N, Weiss HA, Konate I, Kania D, Segondy M, Meda N, van de Perre P, Mayaud P. The Journal of infectious diseases. 2016; 213(5):731-7. PubMed [journal] PMID: 26475931. PMCID: PMC4747618